Current role
Biotechnology · Healthcare
Chairman, Board Member, CEO
2020-01-01–present
Michael Cola
Chairman
Avalo Therapeutics, Inc. (AVTX)Board Member
Avalo Therapeutics, Inc. (AVTX)Equibles does not estimate personal net worth.
Get an email with a short summary when Avalo Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get AVTX alertsAbout Michael Cola
Michael Cola is recorded as Chairman at Avalo Therapeutics, Inc. (AVTX) since June 21, 2021, Board Member at Avalo Therapeutics, Inc. (AVTX) since June 18, 2020 and CEO at Avalo Therapeutics, Inc. (AVTX) since February 3, 2020. The proxy statement of Avalo Therapeutics, Inc. reports total compensation of $945,417 for Michael Cola in fiscal 2022, including a base salary of $62,500. Disclosed compensation is on record for 4 fiscal years. Avalo Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Avalo Therapeutics, Inc. includes Garry A. Neil (CEO), Garry Neil (CEO and Board Member), Michael F. Cola (CEO and Board Member) and 7 others.
Affiliation history
-
Current
2021-06-21–present
-
Current
2020-06-18–present
-
Current
2020-02-03–present
-
2020-01-01–2022-02-16
-
Start not stated–2022-02-14
Company network
Leadership on record at Avalo Therapeutics, Inc.
- Garry A. Neil CEO
- Garry Neil CEO, Board Member
- Michael F. Cola CEO, Board Member
- Peter Greenleaf CEO
- Michael Heffernan Chairman, Board Member
- Sol Barer Chairman, Board Member
- Sol J. Barer Chairman, Board Member
- Chris Sullivan CFO
- Christopher Sullivan CFO, Chief Accounting Officer
- Schond L. Greenway CFO
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Avalo Therapeutics, Inc. (AVTX) | Former Chief Executive Officer and former principal executive officer | $62,500 | $945,417 |
| 2021 | Avalo Therapeutics, Inc. (AVTX) | Former Chief Executive Officer and former principal executive officer | $35,568 | $2,693,811 |
| 2020 | Avalo Therapeutics, Inc. (AVTX) | Former Chief Executive Officer and former principal executive officer | $79,228 | $3,820,306 |
| 2019 | Avalo Therapeutics, Inc. (AVTX) | Chief Executive Officer and principal executive officer | — | — |
Recent activity
No call appearances or filed executive changes recorded yet.